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ABSTRACT 
[248/250 words]  
Objective: Previous cohorts have reported associations between overweight/obesity and knee 
and hand osteoarthritis (OA). However, no data on the effect of these on the OA burden are 
available. We aimed to analyse the effect of overweight and obesity on the incidence of routinely 
diagnosed knee, hip, and hand OA.  
Methods: 
Design: population-based cohort  
Setting: primary care records from the SIDIAP database (>5.5 million subjects) covering >80% 
of the population of Catalonia, Spain. 
Participants:  ≥40 years old with no OA on 01/01/2006 and with body mass index (BMI) data 
available. Follow-up: from 01/01/2006 to 12/31/2010, loss to follow-up, or death. 
Measures: BMI World Health Organization categories (exposure), and incident clinical diagnoses 
of knee, hip, or hand OA (ICD-10 codes). 
Results  
1,764,061 subjects were observed for a median (inter-quartile range) of 4.45 (4.19 to 4.98) years. 
Incidence rates (per 1000 PY) of knee, hip and hand OA ranged from 3.7 (3.6 to 3.8), 1.7 (1.7 to 
1.8) and 2.6 (2.5 to 2.7) amongst normal-weight, to 19.5 (19.1 to 19.9), 3.8 (3.7 to 4.0) and 4.0 
(3.9 to 4.2) in the grade II obese respectively.  
Compared to normal-weight subjects, being overweight or obese increased the risk of OA at all 
three sites, especially at the knee: overweight and (grade I, II) obesity increased knee OA risk by 
a factor of 2, 3.1 and 4.7 fold respectively.  
Conclusions 
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Both overweight and obesity increase the risk of hand, hip, and knee OA, especially for the  
latter, with a dose-response gradient with increasing BMI.  
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Obesity and osteoarthritis (OA) are two interconnected health care problems affecting a large 
proportion of the adult population worldwide. The increasing weight of the population will lead 
to nearly 1.3 billion and 573 million adults overweight and obese respectively by 2030 [1]. 
Moreover, OA increases as the population ages [2] representing a leading cause of chronic pain 
and disability among older people [3]. 
 
There is extensive evidence supporting obesity as one of the major risk factors for knee OA [4-
7,8], independent of the method of assessment used [9]. To a lesser extent there are reports 
associating obesity with hand OA [10,8] and more conflicting results are found regarding hip OA 
[6,7,11,8]. The mechanical overload of the weight-bearing joint or the activation of metabolic 
factors contributing to the joint damage have both been proposed as possible mechanisms to 
explain how weight increases the risk of knee or hand OA [12].  
 
Nevertheless the limited treatments for OA make prevention of modifiable risk factors, such as 
obesity, a key target for public health and medical interventions today. Consequently, the aim of 
this study is to analyse the effect of obesity on the incidence of symptomatic knee, hip and hand 
OA, using a large population database.  
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PATIENTS AND METHODS 
Study design and setting:  
We conducted a population-based cohort study using routinely collected data from the Sistema 
d‘Informació per al Desenvolupament de l‘Investigació en Atenció Primària (SIDIAP) database 
(http://www.sidiap.org). 
Data source:  
SIDIAP gathers clinical information as recorded by general practitioners (GP) and primary care 
nurses including prescriptions, events (ICD-10 codes) and measurements (such as body mass 
index, blood pressure, or spirometry results amongst others collected using structured 
spreadsheets) during routine practice. It covers >5.5 million people (a representative >80% of the 
population of Catalonia, Spain) registered with one of the 3,414 GPs working in any of the 274 
primary care practices run by the Catalan Institute of Health (ICS for its acronym in Catalan 
[15].  
The Spanish (and by extension, the Catalan) healthcare system is of universal coverage, and GPs 
are, as in the British NHS, gatekeepers to any other medical or allied healthcare professional 
attention with the exception of Accident and Emergency rooms. 
Participants:  
Eligible participants were all subjects aged at least 40 years old without a history of diagnosed 
OA in primary care records at index joint on 1st January 2006 and with at least one measurement 
of BMI coded in the primary care computerized records (SIDIAP database)   
Study period:  
Participants were observed from study initiation (1st January 2006) or from the date when they 
registered at any of the primary health care practices covered by the SIDIAP (whatever came 
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last) to the earliest of the following: end of the study (31st December 2010), transfer out of 
catchment area, or death. 
Variables:  
Study exposure: The BMI coded by health care professionals in kg/m2 during the study period 
was the main study exposure. Values of BMI <10 or >60 were assumed as typing errors and not 
used for the current analyses. When more than one measurement was available, the closest to 
index date (1st January/2006) was used. Patients were classified according to the World Health 
Organization definitions in: normal (BMI below 25 kg/m2), overweight (BMI 25 or over and 
below 30 kg/m2), obese grade I (BMI 30 or above and below 35 kg/m2), and obese grade II (BMI 
35 kg/m2 or above). 
Study outcomes: Incident clinical diagnoses of OA as registered by general practitioners during 
the study period (1 January 2006 to 31 December 2010) were identified using a previously 
validated list of ICD-10 codes: knee OA (M17, M17.0, M17.1, M17.2, M17.3, M17.4, M17.5 
and M17.9), hip OA (M16, M16.0, M16.1, M16.2, M16.3, M16.4, M16.5, M16.6, M16.7 and 
M16.9) and hand OA (M15.1, M15.2, M18, M18.0 to M18.5 and M18.9). OA coding within 
SIDIAP has been validated against self-reported OA in the Global Longitudinal Study of 
Osteoporosis in Women (GLOW) population-based cohort [13], as well as by reviewing free text 
and x-ray reports collected in primary care records [14].  
Statistical analyses: 
Age (in 5-year groups) and gender-specific incidence rates (IRs) and 99% Confidence Intervals 
(99%CIs) for each of the outcomes identified in the study period were estimated assuming a 
Poisson distribution.  
Cox regression modelling was used to compute age and gender-adjusted hazard ratios (HRs) and 
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99%CIs for an incident clinical diagnosis of knee, hip, and hand OA according to BMI  
(continuous, per kg/m2 increase) and BMI category (using normal weight as a reference group).  
Age-specific adjusted rate ratios (RRs) for overweight, obese grade I and obese grade II  
compared to normal-weight were calculated using Poisson regression.   
All the statistical analyses were carried out using STATA SE for Mac V.12.0.  
  
Ethical approval:   
Scientific approval was obtained from the SIDIAP Scientific Committee, and ethics approval  
was granted by the relevant board (CEIC IDIAP Jordi Gol) with certificate number P14/153.  
Patient consent was not required as only anonymised retrospective data was used for this study,  
and no patient or GP contact was required.  
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RESULTS  
  
Baseline characteristics  
 A total of 1,764,061 (54.0%) out of 3,266,826 potentially eligible subjects registered in SIDIAP  
had data on BMI, and were therefore included in the study. Compared to the source population,  
the included participants (i.e. with BMI data available) were slightly older (64.1 versus 62.4  
years) and more likely to be women (54.2% versus 51.8%).  
Eligible subjects were categorized into the following BMI categories: 446,034 (25.3%) normal- 
weight, 742,258 (42.1%) overweight, 409,714 (23.2%) grade I obesity, and 166,055 (9.4%)  
grade II obesity. Baseline characteristics of subjects according to their BMI category are shown  
in table 1.  
  
Incidence rates of knee, hip, and hand OA in the study population  
Participants were observed for a median (IQR) of 4.45 (4.19 to 4.98) years. Incidence rates are  
reflected in figures 1, 2 and 3. During this period, 83,469 incident cases with knee OA were  
identified with crude-incidence rates of 9.1, 99%CI (9.0 to 9.2) per 1,000 person-years at risk  
respectively, 27,701 incident cases with hip OA were identified with crude-incidence rates of 2.9  
(2.8 to 2.9) per 1,000 person-years at risk respectively and 30,909 incident cases with hand OA  
were identified with a crude-incidence rates of 3.2 (3.2 to 3.3) per 1,000 person-years at risk  
respectively. Incidence rates of knee, hip and hand OA for each BMI category are represented in  
table 2.   
The incidence rates for knee and hip OA increased since the age of 40 years old with a special  
increase at the age of 55-60 and 70 to 75 years old respectively (figures 1 and 2)  
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Association of BMI and knee, hip and hand OA: 
The incidence of knee, hip, and hand OA increased with increasing BMI, with a greater increase 
for knee OA (figures 1-3). The adjusted HR for the effect of BMI on OA is reported in table 3.  
 
In the fitted survival model, age increased the risk of OA similarly at all three sites (knee, hand 
and hip) whereas female gender increased the risk mostly in hand OA. 
After categorization into WHO-recommended groups, and compared to those with normal 
weight (<25kg/m2), those with overweight had an excess risk of OA, especially at the knee. This 
excess risk continued increasing as the BMI increased, being more pronounced for knee OA in 
subjects with grade 2 obesity (>35kg/m2); these subjects were 4.7 fold more frequently 
diagnosed with knee OA compared to subjects with BMI <25kg/m2. 
The observed associations between overweight/obesity and the risk of knee, hip were present 
throughout all the participant ages (40 years or older) (Figures 1, 2 respectively). However, the 
excess risk of OA associated with obesity varied at different ages for knee OA while this 
association was more constant (unmodified by age) for hip OA, (Figure 4).  
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DISCUSSION  
Principal findings:  
Our study confirms that the incidence of OA mostly affects the knee in our population, compared 
to the other joint sites, reaching a maximum incident rate of 19.5 per 1,000 persons-year for 
subjects with grade II obesity compared to the 3.7 per 1,000 persons-year for normal-weight 
subjects. Obesity seemed to increase the risk in all three joint sites, including the hip, but the 
greatest increase was reported for knee. The effect of obesity on knees was more pronounced at 
younger ages, which could be useful for public health messaging.  
We found a positive association between overweight and obesity with the risk of developing OA 
at the knee, hip and hand. The excess risk found was greater for subjects with grade II obesity, 
who were 4.7 times more likely to develop knee OA compared to subjects with normal-weight.  
 
Strengths and weaknesses of the study:  
Our main strength is the large population included in this study, which allows us to easily 
extrapolate our results using a clinically relevant outcome.  Moreover, to our knowledge this is 
the first study to analyse the impact of obesity on osteoarthritis using routinely collected data 
from primary care. However, this study must be also interpreted in the light of certain 
limitations; the main outcome was based on symptomatic OA and no information was collected 
regarding radiographic OA. However, there is strong evidence that obesity is associated with 
radiographic OA [7], which suggests that our results would remain unchanged. Moreover, 
SIDIAP does not contain information on the side of the joint affected (joint site (eg, knee) was 
considered as a whole and nearly 46% of the subjects had missing information on their BMI. The 
missing BMI could be a source of bias, however the BMI registration in Spain is part of the 
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recommended health check programme called PAPPs required by the government in order to  
give funding to the primary health cares [16], hence it is not always linked to a more pathological  
population but maybe to a population that more frequently uses primary health care resources.  
Moreover, we compared the BMI distribution of the population in our study with another large  
national study carried out in Spain, where the trends of the BMI were analysed on over 11,000  
subjects and found similar percentages of obesity between 2008-2010 [17], witch reinforces the  
representativeness of our population. Conversely, we analysed the IR of knee, hip and hand OA  
in those subjects with missing BMI and found a lower IR of OA in this population (Unadjusted  
IR 2.98 per 1000persons-year for knee, IR 1.03 per 1000 persons-year for hip and IR 1.33 per  
1000 persons-year for hand OA), although we do not think that this invalidates the association  
between BMI and OA at the different sites found in this study, this may limit its  
representativeness. Another limitation to be considered is the lack of information on incident  
overweight subjects during the study period; the information on BMI relied on the available data  
on the SIDIAP database and given that periodic BMI registering is quite uncommon we were not  
able to account for this.   
Despite previous validation of the data collected in the SIDAP database, [13] and due to the  
retrospective nature of this study, the possibility of misclassification and registration biases  
should be considered. Finally, we did not collect information on occupation, physical activity or  
previous injuries, which could have influenced our results. Previous studies have shown an  
increased risk with manual labour occupations and OA [18], while physical activity has been  
found to have an unclear association with OA [6]   
Strength and weaknesses in relation with other studies  
Overweight and obesity have been previously identified as a risk factor for developing OA. This  
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association has been especially reported for knee [4-8] and hand OA [10], with more inconsistent 
results for hip OA [6,7,8,11]. Our results confirm these previous findings for knee and hand OA 
and extend what has been previously published regarding hip OA [11]; compared to those 
subjects with normal-weight, our overweight and grade II obese population had a 46 and a 93% 
excess risk of hip OA respectively. Some previous studies [6-8] did not find an association 
between BMI and hip OA which could be due to the low number of subjects with hip OA 
included (compared to the 27,701 cases found in our population), the self-reported OA [6-7] 
(compared to our routinely collected data by primary health care professionals) or the selection 
of a rather healthy and younger population [6-8], leading to an underestimation of this 
association. Among the studies that did analyze the association between obesity and OA through 
a life-course approach [19-23], early and middle adulthood [19, 20, 22, 23] and up to the age of 
60 years old [20, 22, 23] were identified as periods in life where there was an excess risk of OA 
for obese and overweight subjects. Furthermore, another previous study based on data from the 
National Health Interview Survey in the US [24] found that the incidence of knee OA peaked in 
those subjects aged 55 to 64 years old and was higher among obese subjects. Our results are 
consistent with these findings; compared to the normal-weight subjects those with obesity (grade 
I and II) had an excess risk of OA that varied with age, especially at the knee.  
 
Meaning of the study and implications of current findings:  
Obesity is a modifiable risk factor and correctly identifying the population with a higher risk of 
OA, such as the one identified by our study, could help prevention strategies to reduce the 
symptomatology or even the future progression of OA. Despite that interventions aiming to 
reduce the clinical outcomes of OA have proven to be effective [25,26], changes in peoples 
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lifestyles and habits are not easy to implement. By identifying the age at which obesity would 
more seriously influence the risk of OA, healthcare providers could focus prevention strategies 
on a narrower target population (i.e. middle adulthood).  
 
Unanswered questions and future research 
The mechanism through which obesity increases the risk of OA has not yet been fully elucidated 
and falls outside the scope of this study. Whether the peak excess risk observed in middle 
adulthood for knee and hand OA reflects the pathogenic pathways involved in the appearance of 
OA at the different sites (eg due to the increase in metabolic disorders such as diabetes or due to 
menopause [27,28]) should be investigated in future research.  
 
Conclusions:  
Both overweight and obesity increase the risk of hand, hip, and knee OA, especially for the 
latter, with a dose-response gradient with increasing BMI. Health care providers should 
implement prevention tools, especially focused on these ages, in order to reduce the risk of 
developing OA at these sites.  
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TABLES:  
Table 1 Baseline characteristics of subjects based on their BMI 
category 
 
BMI categories, N , % 
<25 25 to <30 
30 to 
<35 
>35 
Follow-up  
(median (inter-quartile 
range)) 
5.99 
(4.81 -
5.99) 
5.99 
(3.97-
5.99) 
5.99 
(2.83-
5.99) 
5.99 
(1.84-
5.99) 
Gender 
Female 
271,175 
60.8 
350,771 
47.3 
218,236 
53.3 
115,151 
69.3 
Male 
174,859 
39.2 
391,487 
52.7 
191,478 
46.7 
50,904 
30.6 
Age Mean (SD) 
60.7 
(15.2) 
65.1 
(13.9) 
66.1 
(13.1) 
64.4 
(12.9) 
Ischemic heart disease 
2,258 
0.5 
7,664 
1.0 
6,168 
1.5 
2,648 
1.6 
Cerebrovascular disease 
1,735 
0.4 
4,667 
0.6 
3,379 
0.8 
1,339 
0.8 
COPD* 
2,865 
0.6 
7,812 
1.0 
6,346 
1.5 
2,933 
1.8 
Diabetes mellitus 
5,137 
1.15 
20,798 
2.8 
19,541 
4.8 
11,847 
7.1 
Page 21 of 32
John Wiley & Sons
Arthritis & Rheumatology
This article is protected by copyright. All rights reserved.
 22
Hypertension 
16,804 
3.8 
63,659 
8.6 
58,850 
14.4 
32,645 
19.7 
 
* COPD : Chronic obstructive pulmonary disease 
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Table 2 Incident rates (IR) of knee, hip and hand OA per 1,000 persons/year 
 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
* BMI based on WHO definitions: Norma-weight (<25kg/m2), overweight (25 to <30 kg/m2), 
obesity I (30 to <35 kg/m2) and obesity II (35 kg/m2 and over). 
β Osteoarthritis. 
 Incident diagnosed 
site-specific OA (N) 
Crude IR per 1,000 
persons/year (99% CI) 
Knee 
OA
β
 
Overall IR 83,469  9.1 (9.0-9.2) 
BMI* Normal-weight 8,785 3.7 (3.6-3.8) 
Overweight 31,415 8.0 (7.9-8.2) 
Obesity I 27,777 13.5 (13.2-13.7) 
Obesity II 15,492 19.5 (19.1-19.9) 
Hip OA
β
 Overall IR 27,701 2.9 (2.8-2.9) 
BMI* Normal-weight 4,250 1.7 (1.7-1.8) 
Overweight 11,846 2.9 (2.8-3.0) 
Obesity I 8,141 3.6 (3.5-3.7) 
Obesity II 3,464 3.8 (3.7-4.0) 
Hand 
OA
β
 
Overall IR 30,909 3.2 (3.2-3.3) 
BMI* Normal-weight 6,302 2.6 (2.5-2.7) 
Overweight 12,856 3.2 (3.1-3.3) 
Obesity I 8,141 3.7 (3.6-3.8) 
Obesity II 3,610 4.0 (3.9-4.2) 
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Table 3 Adjusted HR [99%CI] for the effect of BMI on OA.  
 
 
All p-vals<0.001 
  
 Any OA Knee OA Hip OA Hand OA 
Age (per year) 1.04 [1.04-1.05] 
 
1.04 [1.04-1.04] 
 
1.05 [1.05-1.05] 
 
1.03 [1.02-1.03] 
 
Sex  Female 
        
1.75 [1.75-1.78] 1.53 [1.51-1.56] 1.20 [1.16-1.23]  2.56 [2.5-2.63] 
BMI 
(kg/m2) 
Overall 1.05 [1.05-1.06] 
 
1.09 [1.08-1.09] 
 
1.04 [1.04-1.04] 
 
1.02 [1.01-1.02] 
 
<25 Ref Ref Ref Ref 
25-30 1.49 [1.46-1.51] 2.00 [1.94-2.06] 
 
1.46 [1.39-1.52] 1.22 [1.17-1.27] 
30-35 1.96 [1.93-2.00] 
 
3.19 [3.09-3.30] 
 
1.75 [1.66-1.83] 
 
1.30 [1.25-1.36] 
 
≥35 2.51 [2.45-2.56] 
 
4.72 [4.56-4.89] 
 
1.93 [1.82-2.05] 
 
1.31 [1.24-1.38] 
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FIGURES 
Figure 1 Incidence of knee OA for each range of BMI* per 1,000/persons-year. 
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* BMI based on WHO definitions: Normal-weight (<25kg/m2), 
overweight (25 to <30 kg/m2), obesity I (30 to <35 kg/m2) and obesity 
II (35 kg/m2 and over). 
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Figure 2 Incidence of hip OA for each range of BMI* per 1,000/persons-year. 
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* BMI based on WHO definitions: Normal-weight (<25kg/m2), 
overweight (25 to <30 kg/m2), obesity I (30 to <35 kg/m2) and obesity 
II (35 kg/m2 and over). 
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Figure 3 Incidence of hand OA for each range of BMI per 1,000/persons-year.  
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* BMI based on WHO definitions: Normal-weight (<25kg/m2), 
overweight (25 to <30 kg/m2), obesity I (30 to <35 kg/m2) and obesity 
II (35 kg/m2 and over). 
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Figure 4 Multivariate Hazard Ratio of the effect of BMI >35 kg/m
2
 on the knee, hip and 
hand compared to BMI <25 kg/m
2
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